Pancreatic Cancer Research

ResearcherGdańsk Medical UniversityNo recent work listed

Julian Świerczyński

Matched on ORCID iD 0009-0005-4824-9651; OpenAlex author ID A5021104852.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 1, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
2
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper

Papers 2

  1. Orlistat Reduces Proliferation and Enhances Apoptosis in Human Pancreatic Cancer Cells (PANC-1). Co-author DOI 10.21873/anticanres.12083↗
  2. Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer. First author DOI 10.3748/wjg.v20.i9.2279↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Tomasz Śledziński · 1 shared paper, 2017
  2. Ewa Sokolowska · 1 shared paper, 2017

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.